Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 112.60
Ask: 113.40
Change: 2.60 (2.36%)
Spread: 0.80 (0.71%)
Open: 112.00
High: 113.40
Low: 110.00
Prev. Close: 110.40
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs

Mon, 21st Dec 2020 15:43

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately reported by Alliance News:

----------

Ferguson PLC - Wokingham, Berkshire-based plumbing and heating products - Hires Suzanne Wood and Brian May as non-executive directors, starting January 1. Wood has been chief financial officer of Vulcan Materials Co, a US producer of construction aggregates, since 2018. Prior to that she was CFO of equipment rental company Ashtead Group PLC. May was CFO of distribution and services firm Bunzl PLC for 14 years before retiring in late 2019. May is currently a non-executive director of water works United Utilities Group PLC and of medical technology company ConvaTec Group PLC

----------

easyJet PLC - Luton Airport-based budget airline - Independent Non-Executive Director Anastassia Lauterbach resigns from board, effective immediately, and so won't stand for re-election at easyJet's annual general meeting on Wednesday.

----------

Direct Line Insurance Group PLC - Bromley, Kent-based motor insurer - Jane Hanson will step down as independent non-executive director at AGM in May, having served for over nine years. Adrian Joseph is hired as a new non-executive director, starting January 1. Joseph is managing director, Group AI & Data Solutions at BT Group PLC. Previously, he was a senior partner at accountants EY and also spent 10 years at Alphabet Inc's Google.

----------

Burford Capital Ltd - London-based law suit finance - Hires Andrea Muller as non-executive director. Muller was a European partner at law firm Shearman & Sterling. Most recently, she was global head of Institutional Business at Principal Global Investors. Muller will be Burford's first female board member.

----------

Distil PLC - London-based premium alcohol brands - Hires Roland Grain as non-executive director, replacing Mark Quinn, effective January 1. Grain is an owner and investor in the spirits industry, including being the owner of Potstill Spirits Trading GmbH, Austria's largest whisky importer and distributor. Distil additionally promotes Marking & Operations Director Kate O'Connell to the board, also from January 1. O'Connell joined Distil as marketing manager in 2011. The company plans to appoint an independent non-executive director and will start looking in the new year.

----------

Syncona Ltd - London-based life sciences investor - Hires Virginia Holmes as non-executive director, starting January 1. Holmes was chief executive of AXA Investment Managers UK, part of French insurer AXA SA, and prior to that was an executive at lender Barclays PLC for more than a decade.

----------

Amur Minerals Corp - nickel-copper sulphide mineral exploration and development in far east of Russia - CFO Paul McKay to leave company on December 31. Contracts with Heytesbury Corporate LLP to provide company secretarial and accounting services.

----------

Henderson International Income Trust PLC - seeks income from non-UK investments - Hires Joanne Parfrey as non-executive director, starting January 1. Parfrey is a chartered accountant who currently is a non-executive director of Octopus AIM VCT PLC, among other positions.

----------

Block Energy PLC - development and production in Georgia - Hires Dato Sandroshvili as independent non-executive director, effective immediately. Sandroshvili is CFO of New Age (African Global Energy) Ltd. Previously, he was director of Strategy, Commercial & Portfolio at former London listing Ophir Energy PLC.

----------

Kainos Group PLC - London-based IT provider with Digital Services and Workday Practice businesses - Hires Rosaleen Blair as non-executive director, starting January 1. Blair is founder & chair of Alexander Mann Solutions, which provides workforce solutions, and had served as its chief executive for 23 years.

----------

FBD Holdings PLC - Dublin-based property and casualty insurer - Confirms Tomas O'Midheach will join as CEO on January 4, replacing Interim CEO Paul D'Alton. FBD had announced O'Midheach's appointment back in July. He left Dublin-based lender AIB Group PLC after 14 years in November, ending as AIB's chief operating officer.

----------

River & Mercantile UK Micro Cap Investment Co Ltd - Hires Stephen Coe as non-executive director, starting January 1. Coe is a chartered accountant, specialising in offshore investment funds. He currently is a non-executive director of Weiss Korea Opportunity Fund Ltd and of Merian Chrysalis Investment Co Ltd, which changed its name on Monday to Chrysalis Investments Ltd.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 May 2022 13:01

Syncona invests USD54 million in SwanBio Therapeutics funding round

(Alliance News) - Syncona Ltd said on Wednesday it invested USD54 million in neurological disorder-focused gene therapy company SwanBio Therapeutics' Series B financing round.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
11 May 2022 09:30

Syncona investee Freeline narrows quarterly loss as costs fall

(Alliance News) - Healthcare company investor Syncona Ltd on Wednesday noted that its portfolio company Freeline Therapeutics PLC trimmed its loss for the first quarter of 2022.

Read more
10 May 2022 14:26

IN BRIEF: Syncona investee Achilles widens quarterly loss on costs

Syncona Ltd - investor in healthcare companies - Notes investee company Achilles Therapeutics PLC posts widened loss amid rising research & development costs. Pretax loss in the quarter ended March 31 widens to USD17.3 million from USD13.8 million a year ago. Research & development costs surge to USD13.0 million from USD8.9 million, mainly due to increased activity in ongoing clinical trials. Cash and equivalents on March 31 fall to USD236.9 million from USD266.3 million as of December 31. "The company anticipates that its cash and cash equivalents are sufficient to fund its planned operations into the second half of 2024," Achilles says.

Read more
5 May 2022 12:59

IN BRIEF: Syncona's investee Autolus widens quarterly loss as costs up

Syncona Ltd - London-based healthcare & investment company - Reports quarterly loss for its portfolio company Autolus Therapeutics PLC as research costs rise. Net loss widens to USD42.7 million from USD39.0 million a year ago. Research & development expenses rise to USD34.0 million from USD30.7 million, Syncona explains.

Read more
28 Apr 2022 12:52

IN BRIEF: Syncona invests GBP15 million more in OMass Therapeutics

Syncona Ltd - London-based investment company - Invests more into OMass Therapeutics, an Oxford University biotechnology spin-out. After the new GBP15 million investment, Syncona now holds a 31% stake worth GBP44 million in the developer of small molecule drugs. The GBP15 million is part of an oversubscribed GBP75.5 million second round of funding for OMass, which now has raised GBP119 million in total.

Read more
28 Apr 2022 08:59

Syncona takes part in oversubscribed funding round for OMass

(Sharecast News) - Syncona committed further funding for rare-disease specialist OMass Therapeutics alongside a syndicate of investors which included a unit of French drug giant Sanofi.

Read more
11 Apr 2022 09:25

Syncona's investee Anaveon receives good trial data

(Alliance News) - Syncona Ltd on Monday noted that its portfolio company Anaveon AG received "encouraging" first clinical data from its ongoing phase I/II study for ANV419.

Read more
11 Apr 2022 07:49

Syncona's Anaveon to present first clinical data from ANV419 study

(Sharecast News) - Healthcare company Syncona said on Monday that its portfolio company, Anaveon AG, a clinical-stage immuno-oncology business, had announced that the first clinical data from the ongoing Phase I/II study of its lead programme, ANV419, would be presented in a poster at the American Association for Cancer Research's annual meeting in New Orleans.

Read more
1 Apr 2022 07:32

Syncona notes portfolio company Freeline annual loss widens in 2021

(Alliance News) - Syncona Ltd said on Friday that portfolio company Freeline Therapeutics Holdings PLC suffered a widened loss last year.

Read more
11 Mar 2022 08:44

Syncona to invest further USD20 million in Freeline Therapeutics

(Alliance News) - Syncona Ltd said on Friday that it agreed to invest USD20.0 million in Freeline Therapeutics Holdings PLC, as part of the investee's USD26.1 million American depositary shares offering.

Read more
18 Feb 2022 10:03

Syncona completes USD1.5 billion sale of Gyroscope to Novartis

(Alliance News) - Syncona Ltd on Friday said it has completed the sale of Gyroscope Therapeutics Holding PLC to Novartis AG.

Read more
10 Feb 2022 07:47

Syncona's Q3 a 'period of significant activity'

(Sharecast News) - Life sciences firm Syncona said on Thursday that the third quarter had been a "period of significant activity", with $674.0m raised by its portfolio and its third successful exit to date.

Read more
8 Feb 2022 20:38

IN BRIEF: Syncona's Freeline says FLT190 drug "well tolerated"

IN BRIEF: Syncona's Freeline says FLT190 drug "well tolerated"

Read more
22 Dec 2021 17:03

LONDON MARKET CLOSE: Omicron hope lifts FTSE despite UK virus surge

LONDON MARKET CLOSE: Omicron hope lifts FTSE despite UK virus surge

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.